GOLDMAN SACHS GROUP INC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 75 filers reported holding DESIGN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,049,016
-62.8%
444,498
-0.7%
0.00%
-100.0%
Q2 2023$2,818,721
+62.5%
447,416
+48.8%
0.00%
Q1 2023$1,734,601
-38.4%
300,624
+9.5%
0.00%
-100.0%
Q4 2022$2,816,073
-83.0%
274,471
-72.4%
0.00%
-75.0%
Q3 2022$16,614,000
+1201.0%
993,645
+989.1%
0.00%
Q2 2022$1,277,000
-32.5%
91,237
-22.1%
0.00%
Q1 2022$1,892,000
+30.3%
117,132
+72.7%
0.00%
Q4 2021$1,452,000
+79.3%
67,838
+23.0%
0.00%
Q3 2021$810,000
+93.3%
55,134
+161.6%
0.00%
Q2 2021$419,000
-83.2%
21,078
-74.7%
0.00%
-100.0%
Q1 2021$2,495,00083,4500.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders